文献速递脑血管病神经重症与神经感染

急性缺血性卒中血管内治疗中全身麻醉与非全身麻醉:随机对照试验的系统综述与贝叶斯荟萃分析

General Anesthesia Versus Non-GA in Endovascular Therapy for Acute Ischemic Stroke: A Systematic Review and Bayesian Meta-Analysis of RCTs.
PubMed 文献 · Neurology · 2026-07-16

结果显示GA的功能独立后验优势概率为94.2%(OR 1.24,95%CrI 0.94-1.66),成功再灌注率更高(OR 1.73,95%CrI 1.23-2.43),90天死亡率无实质差异。

要点

  • GA与功能独立的后验优势概率为94.2%,提示可能优于非GA策略。
  • GA组成功再灌注率更高(OR 1.73,95%CrI 1.23-2.43)。
  • GA组术中低血压风险明显增加(OR 4.28,95%CrI 2.35-7.86)。

核心结论

  • 贝叶斯荟萃分析提示急性缺血性卒中血管内治疗中GA与功能结局改善相关,挑战了既往等效性结论,但仍需确证性证据。

研究设计与样本

  • 遵循PRISMA 2020指南的系统综述与贝叶斯随机效应荟萃分析。
  • 检索PubMed/MEDLINE、Embase和Cochrane Central Register of Controlled Trials,检索时间自建库至2026年1月3日。

主要发现

  • 功能独立(mRS 0-2)的GA后验优势概率为94.2%(OR 1.24,95%CrI 0.94-1.66)。
  • 成功再灌注(TICI 2b-3)GA组更高(OR 1.73,95%CrI 1.23-2.43;P优势>99%)。
  • 90天死亡率(OR 0.92,95%CrI 0.67-1.27;P优势69%)、极佳功能结局(mRS 0-1;OR 1.06,95%CrI 0.80-1.41;P优势67%)和症状性颅内出血(OR 0.93,95%CrI 0.56-1.52;P优势62%)无实质差异。
  • GA与术中低血压增加相关(OR 4.28,95%CrI 2.35-7.86;P优势0.01%)及肺炎风险增加(OR 1.60,95%CrI 0.95-2.81;P优势3%)。

关键数值与推荐

  • 后验优势概率超过80%被视为实质性获益证据。
  • 功能独立的后验优势概率为94.2%,成功再灌注的P优势>99%。

临床怎么用

  • 结果提示GA可能更优,但需结合开放标签设计和异质性非GA对照解读,尚需确证性证据。

局限性

  • 纳入试验多为开放标签设计。
  • 非GA对照策略存在异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Endovascular thrombectomy (EVT) improves outcome in acute ischemic stroke (AIS) due to large vessel occlusion, yet the optimal anesthetic strategy remains controversial. Previous meta-analyses using frequentist methods reported no significant differences between general anesthesia (GA) and non-GA techniques; however, a recently published trial reported a high posterior probability of functional benefit with GA. We aimed to update the existing systematic review and to re-examine the cumulative randomized evidence using Bayesian statistical methods. METHODS: We conducted a systematic review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. PubMed/MEDLINE, Embase, and Cochrane Central Register of Controlled Trials were searched from inception to January 3, 2026, for randomized controlled trials (RCTs) comparing GA with non-GA strategies during EVT in adults with AIS. Primary outcomes were functional independence (modified Rankin Scale [mRS] 0-2) at 90 days, successful reperfusion (thrombolysis in cerebral ischemia 2b-3), and 90-day mortality. Bayesian random-effects meta-analyses with weakly informative priors were performed. Results are reported as odds ratio (OR) or mean difference (MD) with 95% credible intervals (CrIs). A posterior probability of superiority exceeding 80% was considered substantial evidence of benefit. Meta-regression and sensitivity analyses were conducted. RESULTS: Ten RCTs (n = 1,601; mean age 70.0 years; 46.6% female) were included. For functional independence, GA was associated with a 94.2% posterior probability of superiority (OR 1.24, 95% CrI 0.94-1.66). GA was associated with higher successful reperfusion rates (OR 1.73, 95% CrI 1.23-2.43; P (superiority) > 99%). No substantial differences were observed for 90-day mortality (OR 0.92, 95% CrI 0.67-1.27; P [superiority] 69%), excellent functional outcome (mRS 0-1; OR 1.06, 95% CrI 0.80-1.41; P [superiority] 67%), or symptomatic intracranial hemorrhage (OR 0.93, 95% CrI 0.56-1.52; P [superiority] 62%). GA was associated with increased intraoperative hypotension (OR 4.28, 95% CrI 2.35-7.86; P [superiority] 0.01%) and increased pneumonia risk (OR 1.60, 95% CrI 0.95-2.81; P [superiority] 3%). DISCUSSION: This meta-analysis using a Bayesian approach provides evidence that GA during EVT for AIS is associated with improved functional outcomes, challenging previous conclusions of equivalence. These findings should be interpreted considering open-label designs and heterogeneous non-GA comparators. They suggest that GA may be preferred but confirmatory evidence is needed.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Heesen P, Ciobanu-Caraus O, Azem K, et al. General Anesthesia Versus Non-GA in Endovascular Therapy for Acute Ischemic Stroke: A Systematic Review and Bayesian Meta-Analysis of RCTs. Neurology. 2026. PMID: 42462185. doi:10.1212/WNL.0000000000218282

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。